CD138 Myeloma Test Package | Lahalak Platform
A comprehensive package for detecting multiple myeloma and plasma cell disorders, providing accurate diagnosis of abnormal cell aggregates in the bone marrow to ensure early treatment initiation.
Scientific name: Immunohistochemistry: CD138 Diagnostic Package
This diagnostic package, based on immunohistochemistry, includes the examination of a range of markers to evaluate and diagnose tumors and diseases involving plasma cells. The package primarily includes the examination of CD138 (Syndecan-1), a highly sensitive membrane marker for mature plasma cells, along with essential complementary markers: Kapp...
Service type
Immunohistochemistry (IHC) Diagnostic Package
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Comprehensive examination of the core immunological marker panel for the diagnosis of plasma cell diseases (CD138, Kappa, Lambda).
- The Ki-67 proliferation marker was examined to assess the rate of plasma cell division (an indicator of aggressiveness).
- Consultation for interpretation of the overall results with a pathologist specializing in hematology and bone marrow tumors.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) from a bone marrow biopsy specimen (trephine biopsy) or from suspected infiltrative tissue.
- It is necessary to attach the initial pathology report, the results of blood and urine tests (protein electrophoresis, immunohistochemistry), and the complete clinical history.
- The patient does not need to fast, as the sample is tissue-based.
- The completion time ranges from 5 to 10 working days.
Medical services you might also like
